Martin M, Schneider H, Azouz A, Rudd C E
Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Boston, MA 02115, USA.
J Exp Med. 2001 Dec 3;194(11):1675-81. doi: 10.1084/jem.194.11.1675.
Coreceptors CD28 and cytotoxic T lymphocyte antigen (CTLA)-4 have opposing effects on TcR/CD3 activation of T cells. While CD28 enhances and CTLA-4 inhibits activation, the underlying molecular basis of these effects has yet to be established. In this context, ganglioside and cholesterol enriched membrane microdomains (rafts, GEMs) serve as centers of signaling in T cells. Although CD28 can promote TcR/raft colocalization, evidence is lacking on whether the surface expression of membrane rafts can be targeted by CTLA-4 in its modulation of T cell responses. In this study, we demonstrate that both CD28 and CTLA-4 profoundly alter the surface expression of membrane rafts during T cell activation. While CD28 increased expression and the number of peripheral T cells induced to express surface rafts in response to TcR ligation, CTLA-4 potently inhibited both TcR and TcR x CD28 induced raft expression on the surface of T cells. Consistent with this, CD28 increased the presence of the linker of activated T cells (LAT) in purified membrane rafts, while CTLA-4 coligation effectively blocked this increase. Further, the reversal of the CTLA-4 block with CD3/CD28 ligation was accompanied by an increase in surface raft expression and associated LAT. Our observations demonstrate for the first time that CTLA-4 targets the release of rafts to the surface of T cells, and provides a mechanism for the opposing effects of CD28 and CTLA-4 on costimulation.
共受体CD28和细胞毒性T淋巴细胞抗原(CTLA)-4对T细胞的TcR/CD3激活具有相反的作用。虽然CD28增强激活而CTLA-4抑制激活,但这些作用的潜在分子基础尚未明确。在此背景下,富含神经节苷脂和胆固醇的膜微结构域(脂筏,GEMs)作为T细胞信号传导的中心。尽管CD28可促进TcR/脂筏共定位,但缺乏关于CTLA-4在调节T细胞反应时是否可靶向膜脂筏表面表达的证据。在本研究中,我们证明CD28和CTLA-4在T细胞激活过程中均会深刻改变膜脂筏的表面表达。CD28增加了外周T细胞的表达以及响应TcR连接而诱导表达表面脂筏的细胞数量,而CTLA-4则强烈抑制TcR和TcR×CD28诱导的T细胞表面脂筏表达。与此一致的是,CD28增加了纯化膜脂筏中活化T细胞连接蛋白(LAT)的存在,而CTLA-4共连接有效地阻断了这种增加。此外,用CD3/CD28连接逆转CTLA-4阻断伴随着表面脂筏表达和相关LAT的增加。我们的观察首次证明CTLA-4靶向脂筏向T细胞表面的释放,并为CD28和CTLA-4在共刺激方面的相反作用提供了一种机制。